FDA Approved: DESVENLAFAXINE SUCCINATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for desvenlafaxine succinate (generic) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate (Desvenlafaxine succinate)

Snippet

SUPPL AP for DESVENLAFAXINE SUCCINATE (DESVENLAFAXINE SUCCINATE)